SAN DIEGO, Dec. 28, 2024 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) common stock pursuant and/or traceable to Kyverna's registration statement issued in connection with Kyverna's initial public...
Read More Details
Finally We wish PressBee provided you with enough information of ( KYTX INVESTOR NOTICE: Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit )
Also on site :
- Kylie Kelce Admits to Fighting Back Laughter After Daughter Dropped a Bit of Zillennial Slang Mid-Convo
- Anne Burrell's Memorial Included 'Big Send-Off' of Billy Joel Karaoke With Food Network Colleagues
- NYT Mini Crossword Answers, Hints for Saturday, June 21, 2025